Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel to Medtronic, Inc., the global leader in medical technology headquartered in Minneapolis (NYSE: MDT), in its transaction with QT Vascular Ltd. for the option to acquire QT Vascular’s non-drug coated Chocolate® PTA. QT Vascular is a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease.

Fredrikson’s legal team was led by Robert Oberlies, Jeffrey Steinle, Ann Ladd, Asmah Tareen and Carrie Rosenberry.

Read the news release.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.